期刊文献+

碘美普尔(碘浓度400 mg/ml)肝脏CT应用专家共识 被引量:12

Expert consensus on liver imaging with iomeprol(400 mg/ml)
原文传递
导出
摘要 碘浓度为400 mg/ml的碘美普尔(简称碘美普尔400)在肝脏等腹部实质脏器的CT动态增强扫描以及CT血管成像检查方面具有独特的优势。但对于如何结合中高端多层螺旋CT设备更好发挥其高浓度特点,尚缺乏统一的认识。基于这个问题,中华医学会放射学分会腹部学组组织相关专家经多次讨论,对碘美普尔400的肝脏CT应用达成共识,对碘美普尔400在肝脏CT血管成像、肝脏实质成像、降低辐射剂量及降低对比剂用量方面的应用优势进行阐述,并推荐扫描方案。
作者 李欣 赵心明 无;Li Xin;Zhao Xinming(Chinese Medical Association Radiology Society Abdomen Group;Department of Radiology,Union Hospital of Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China;Department of Medical Imaging,Cancer Hospital,Chinese Academy of Medical Sciences,Beijing 100021,China)
出处 《中华放射学杂志》 CAS CSCD 北大核心 2020年第1期3-8,9,共7页 Chinese Journal of Radiology
  • 相关文献

参考文献2

二级参考文献53

  • 1吴新民,薛张纲,王俊科,叶铁虎,赵晶.围术期过敏反应诊治的专家共识[J].中国继续医学教育,2011,3(10):129-130. 被引量:34
  • 2全国eGFR课题协作组.MDRD方程在我国慢性肾脏病患者中的改良和评估[J].中华肾脏病杂志,2006,22(10):589-595. 被引量:702
  • 3ACR Manual on Contrast Media version 9. ACR Committee on Drugs and Contrast Media. 2013.
  • 4Solomon RJ, Natarajan MK, Doucet S, et al. Cardiac angiography in renally impaired patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation, 2007, 115:3189-3196.
  • 5ESUR Guidelinesversion 8. ESUR Contrast Media Safety Committee. 2012.
  • 6Lang DM, Alpern MB, Visintainer PF, et al. Elevated risk of anaphylactic reaction from radiographic contrast media is associated with both beta-blocker exposure and cardiovascular disorders. Arch Intern Med, 1993, 153:2033-2040.
  • 7Chen Y, Hu S, Liu Y, et al. Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study. Eurlntervention, 2012, 22:830-838.
  • 8Wright RS, Anderson JL, Adams CD, et al. 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 2011, 123:2022-2060.
  • 9Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/ SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation, 2011, 124:e574-e651.
  • 10Hamm CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J , 2011, 32:2999-3054.

共引文献266

同被引文献110

引证文献12

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部